Загрузка...
N-of-1 Trials of Expensive Biological Therapies: A Third Way?
In developing policies for use of expensive agents, such as those used for the treatment of rheumatoid arthritis, managed care organizations have invoked “stepped care,” in which physicians and patients must first try more established and less costly agents. N-of-1 clinical trials are multiple cross...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2715700/ https://ncbi.nlm.nih.gov/pubmed/18504330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archinte.168.10.1030 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|